Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Healthtrust
Baxter
McKesson
Harvard Business School
McKinsey
US Department of Justice
Dow
Cantor Fitzgerald
Medtronic

Generated: August 16, 2017

DrugPatentWatch Database Preview

Casper Pharma Llc Company Profile

« Back to Dashboard

What is the competitive landscape for CASPER PHARMA LLC, and what generic and branded alternatives to CASPER PHARMA LLC drugs are available?

CASPER PHARMA LLC has eight approved drugs.



Summary for Applicant: Casper Pharma Llc

Patents:0
Tradenames:8
Ingredients:8
NDAs:8
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Casper Pharma Llc
FURADANTIN
nitrofurantoin
SUSPENSION;ORAL009175-001Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe
Casper Pharma Llc
CORTISPORIN
bacitracin zinc; hydrocortisone; neomycin sulfate; polymyxin b sulfate
OINTMENT;OPHTHALMIC050416-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Casper Pharma Llc
ANTIVERT
meclizine hydrochloride
TABLET;ORAL010721-006Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Casper Pharma Llc
ANTIVERT
meclizine hydrochloride
TABLET, CHEWABLE;ORAL010721-005Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Casper Pharma Llc
ANTIVERT
meclizine hydrochloride
TABLET;ORAL010721-001Jan 20, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Casper Pharma Llc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Casper Pharma Llc
THALITONE
chlorthalidone
TABLET;ORAL019574-001Dec 20, 1988► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for CASPER PHARMA LLC drugs

Drugname Dosage Strength Tradename Submissiondate
glycopyrrolate
Tablets2 mg
ROBINUL FORTE
10/12/2010
glycopyrrolate
Tablets1 mg
ROBINUL
8/14/2009
glycopyrrolate
Tablets1.5 mg
ROBINUL FORTE
5/6/2009

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
McKesson
Federal Trade Commission
AstraZeneca
Fish and Richardson
Queensland Health
Deloitte
Chinese Patent Office
Covington
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot